| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/19/2007 | WO2007042602A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 04/19/2007 | WO2005051329A3 Systems and methods for altering vestibular biology |
| 04/19/2007 | WO2005020893A3 Therapeutic platelets and methods |
| 04/19/2007 | WO2005011615A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 04/19/2007 | WO2004112694A3 Immunogenic reagents from west nile virus |
| 04/19/2007 | WO2004091475A3 Gaucher disease drugs and methods of identifying same |
| 04/19/2007 | US20070088163 Modulators of calcitonin and amylin activity |
| 04/19/2007 | US20070088076 conjugated of a second-generation taxoid ( ortataxel or SB-T-1104( frag sheet) and an omega-3 fatty acid selected from docosahexanoic acid, eicosapentaenoic acid and alpha-linolenic acid for treting cancer |
| 04/19/2007 | US20070088006 Preemptive Prophylaxis of Migraine |
| 04/19/2007 | US20070088002 Orally available sphingosine 1-phosphate receptor agonists and antagonists |
| 04/19/2007 | US20070087984 Method of identifying agents that inhibit the growth of cancer cells |
| 04/19/2007 | US20070087004 Pro104 antibody compositions and methods of use |
| 04/19/2007 | US20070086999 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 04/19/2007 | US20070086967 Treatment of psoriasis with rosiglitazone |
| 04/19/2007 | CA2623518A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 04/18/2007 | EP1774969A2 Controlled release oxycodone compositions |
| 04/18/2007 | EP1774952A2 Stable cosmetic emulsion with polyamide gelling agent |
| 04/18/2007 | EP1773386A2 Vaccine compositions and methods |
| 04/18/2007 | EP1773368A2 A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 04/18/2007 | EP1773297A1 Infusion and injection solution of levodopa |
| 04/18/2007 | EP1597267A4 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 04/18/2007 | EP1567171B1 Use of dextran sulfate for treating ibmir |
| 04/18/2007 | EP1476162B1 Controlled synthesis of ziprasidone |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1343525B1 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE |
| 04/18/2007 | CN1310872C Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/18/2007 | CN1310689C Keratin fibre dyeing composition using cation direct dye and thickening polymer |
| 04/18/2007 | CN1310688C Keratin fibre hair dye composite containing cation direction dye and polymer thickening agent |
| 04/18/2007 | CN1310678C Administration of agents for the treatment of inflammation |
| 04/18/2007 | CN1310673C Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 04/17/2007 | USRE39576 Inhibitors of inducible nitric oxide synthase, as hypotensive agent, antiinflammatory agent, antiarthritic agent |
| 04/17/2007 | US7205378 therapeutic agent is reversibly immobilized on polymer matrix using ionic complexation between latent carboxylic groups present on the lactone bearing polymer matrix and a cationic group on the therapeutic agent; drug delivery |
| 04/17/2007 | US7205292 Piperidines containing a lactam ring and a quinolinone, benzimidazolone, quinazolinone or benzodiazepinone group, e.g. N-[3R,7R)-1-(Cyclopropylmethyl)-2-oxo-7-phenylazepan-3-yl]-4-(2-oxo-1,4-dihydroquinazolin-3 (2H-yl)piperidine-1-carboxamide; treating headaches, migraine headaches and cluster headaches |
| 04/17/2007 | US7205287 Platinum complexes having antitumor activity |
| 04/17/2007 | US7205007 Peri-operative and peri-procedure nutritional supplementation |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2182417C Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 04/12/2007 | WO2005032492A3 Site and rate selective prodrug formulations of d609 with antioxidant and anticancer activity |
| 04/12/2007 | WO2004071408A3 Aβ BINDING MOLECULES |
| 04/12/2007 | US20070083006 Method for preparation of site-specific protein conjugates |
| 04/12/2007 | US20070082971 Use of a plastic composition and a product obtained thereby |
| 04/12/2007 | US20070082948 Compounds and methods for delivery of prostacyclin analogs |
| 04/12/2007 | US20070082906 1-(1-{4-[3-(1,3-oxazol- 2-yl)-6-phenyl-1,2,4- triazin-5- yl]benzyl}piperidin-4- yl)-1,3-dihydro-2H- benzimidazol-2-one; inhibit activity of a serine, threonine protein kinase; hyperproliferative disorders, restenosis, inflammation, autoimmune diseases, allergy, asthma |
| 04/12/2007 | US20070082884 Selective serine/threonine kinase inhibitors |
| 04/12/2007 | US20070082868 Seaweed extract composition for treatment of diabetes and diabetic complications |
| 04/12/2007 | US20070082851 Treatment of a condition in a mammal with administration of Compounds and Methods of Use |
| 04/12/2007 | US20070082397 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 04/12/2007 | US20070082335 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/12/2007 | US20070082062 Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate |
| 04/12/2007 | US20070082009 Methods of preparation of live attenuated bacterial vaccine by alteration of dna adenine methylase (dam) activity in those bacteria |
| 04/12/2007 | US20070081981 Expanding population of human hematopoietic stem cells via reduction in activity of cyclin dependent kinases utilizing small RNA interfering; tissue regeneration |
| 04/12/2007 | US20070081943 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 04/11/2007 | EP1772151A2 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/11/2007 | EP1771151A1 Composition, compising hydrofluoric acid, for inhibiting dental erosion |
| 04/11/2007 | EP1458689B1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 04/11/2007 | EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents |
| 04/11/2007 | CN1946416A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309399C Compound 'Shuanghuanglian' preparation and preparing process thereof |
| 04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
| 04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
| 04/10/2007 | US7202251 Bicyclic anilide spirohydantoin CGRP receptor antagonists |
| 04/10/2007 | US7202234 Compounds and methods for treating Toll-like receptor 2-related diseases and conditions |
| 04/10/2007 | CA2470066C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/10/2007 | CA2277172C Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 04/10/2007 | CA2168671C A method for high loading of vesicles with biopolymeric substances |
| 04/10/2007 | CA2162821C Multilayer bicarbonate/peroxide dentifrice |
| 04/05/2007 | WO2005000229A3 Compositions and methods for modulating s-nitrosoglutathione reductase |
| 04/05/2007 | WO2004093808A3 Novel tumor-associated antigens |
| 04/05/2007 | US20070078186 Methods for treating transthyretin amyloid diseases |
| 04/05/2007 | US20070078182 Compounds and methods for delivery of prostacyclin analogs |
| 04/05/2007 | US20070078106 A 5-substituted uracil or 5,6-dihydro-5-substituted uracil, potentiate 5-fluorouracil; 5-substituent is selected from bromo, ido, cyano, halo-substituted C1-4 alkyl, C2-6 alkenyl, 1-halo-C2-6 alkenyl andhalo-substituted C2-6 alkynyl; antitumor agents; anticarcinogenic agents |
| 04/05/2007 | US20070078095 Compounds and methods for delivery of prostacyclin analogs |
| 04/05/2007 | US20070078093 Methods and compositions for treating cancer |
| 04/05/2007 | US20070078092 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 04/05/2007 | US20070078084 Compositions and methods related to production of erythropoietin |
| 04/05/2007 | US20070077651 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides |
| 04/05/2007 | US20070077641 Methionine aminopeptidase and methods of use |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077592 Hemipteran glutamate decarboxylase |
| 04/05/2007 | US20070077559 Newcastle disease virus administration |
| 04/05/2007 | US20070077260 Vaccines for mycoplasma bovis and methods of use |
| 04/05/2007 | US20070077225 Continuous delivery methods for treating hepatitis virus infection |
| 04/05/2007 | US20070077198 precursor for preparing 3'-Deoxy-3'-[18F]-fluoro-thymidine (18F-FLT), that has been used for visualizing DNA in Positron emission tomography; produces low amounts of chromophoric byproducts during the deprotection step in preparation process |
| 04/05/2007 | US20070077196 Radiolabeled thymidine solid-phase extraction purification method |
| 04/04/2007 | EP1554235A4 Process for synthesizing l-y-methylene glutamic acid and analogs |
| 04/04/2007 | EP1545584A4 Method for reducing morbidity and mortality in critically ill patients |
| 04/04/2007 | EP1541673B1 Probiotics for pet food applications |
| 04/04/2007 | EP1377556B1 Pyrazole derivatives for treating hiv |
| 04/04/2007 | EP1362033B1 Pyridine matrix metalloproteinase inhibitors |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942193A Pharmaceutical compositions for acute glucocorticoid therapy |
| 04/04/2007 | CN1942176A Pharmaceutical compositions for glucocorticoid replacement therapy |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1939917A Cannabinol derivatives and pharmaceutical use thereof |
| 04/04/2007 | CN1939903A Mandelic acid derivatives and their use as throbin inhibitors |
| 04/04/2007 | CN1939902A Mandelic acid derivatives and their use as throbin inhibitors |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939304A Ascending-dose dosage form |